Anakinra in hospitalized COVID-19 patients guided by baseline soluble urokinase plasminogen receptor plasma levels: A real world, retrospective cohort study.

Francesco Vladimiro Segala Emanuele RandoFederica SalvatiMarcantonio NegriFrancesca CataniaFlavia SanmartinRita MurriEvangelos J Giamarellos-BourboulisMassimo Fantoni

Published in: PloS one (2023)

This real-word, retrospective cohort study confirmed the safety and the efficacy of suPAR-guided, early use of anakinra in hospitalized COVID-19 patients with respiratory failure.

Keyphrases

respiratory failure
sars cov
extracorporeal membrane oxygenation
coronavirus disease
mechanical ventilation
respiratory syndrome coronavirus
binding protein